US FDA approves Novo Nordisk's Ozempic to cut risk of diabetic kidney disease progression
The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...
Novo Nordisk's Ozempic gets FDA approval for kidney disease
Novo Nordisk (NVO) said its popular diabetes drug Ozempic, or semaglutide, has been approved for the treatment of patients ...
Novo Nordisk’s Ozempic Gets FDA Approval as Kidney-Disease Treatment
Ozempic, or semaglutide, can now be used to reduce the risk of worsening kidney disease or kidney failure in adults with type ...
F.D.A. Approves Ozempic to Treat Kidney Disease
The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have ...
Contract Pharma19h
FDA Grants 510(k) Clearance for Fresenius Kabi’s Adaptive Nomogram
The U.S. Food and Drug Administration (FDA) has granted 510 (k) clearance for Fresenius Kabi’s Adaptive Nomogram, an ...
Endovascular Today18h
Instylla’s Tembo Embolic System Receives FDA Clearance
Instylla, Inc., a developer of solutions for peripheral vascular embolotherapy, announced the FDA 510(k) clearance of the Tembo ...